REFERENCES
1. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
2. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57-185.
3. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 2015;36:3075-128.
4. Pettersson GB, Coselli JS, Pettersson GB, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines. J Thorac Cardiovasc Surg 2017;153:1241-1258.e29.
5. Nakatani S, Ohara T, Ashihara K, et al. JCS 2017 guideline on prevention and treatment of infective endocarditis. Circ J 2019;83:1767-809.
6. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. J Thorac Cardiovasc Surg 1995;110:1745-55.
7. Gillinov AM, Shah RV, Curtis WE, et al. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996;61:1125-30.
8. Wilbring M, Irmscher L, Alexiou K, Matschke K, Tugtekin SM. The impact of preoperative neurological events in patients suffering from native infective valve endocarditis. Interact Cardiovasc Thorac Surg 2014;18:740-7.
9. Ruttmann E, Willeit J, Ulmer H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006;37:2094-9.
10. García-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis. Circulation 2013;127:2272-84.
11. Okita Y, Minakata K, Yasuno S, et al. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study. Eur J Cardiothorac Surg 2016;50:374-82.
12. Shang E, Forrest GN, Chizmar T, et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg 2009;87:1728-33.
13. Yoshioka D, Toda K, Sakaguchi T, et al. Valve surgery in active endocarditis patients complicated by intracranial haemorrhage. Eur J Cardiothorac Surg 2014;45:1082-8.
14. Kume Y, Fujita T, Fukushima S, et al. Intracranial mycotic aneurysm is associated with cerebral bleeding post-valve surgery for infective endocarditis. Interact Cardiovasc Thorac Surg 2018;27:635-41.
15. Tam DY, Yanagawa B, Verma S, et al. Early vs late surgery for patients with endocarditis and neurological injury. Can J Cardiol 2018;34:1185-99.
16. Hart RG, Kagan-hallet K, Joerns SE. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 1987;18:1048-56.
17. Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage. Stroke 2008;39:2304-9.
18. Parry-Jones AR, Abid KA, Di Napoli M, et al. Accuracy and clinical usefulness of intracerebral hemorrhage grading scores: a direct comparison in a UK population. Stroke 2013;44:1840-5.
19. Lakhan SE, Kirchgessner A, Tepper D, Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol 2013;4:32.
20. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-11.
21. Maruyama R, Yamada A, Sugiyama T, et al. Mitral valve repair for endocarditis can be performed 3 days after repair of a bleeding mycotic brain aneurysm. J Thorac Cardiovasc Surg 2016;151:e59-61.
22. Salaun E, Touil A, Hubert S, et al. Intracranial haemorrhage in infective endocarditis. Arch Cardiovasc Dis 2018;111:712-21.
23. Tanaka K, Morimoto T, Yada I, Kusagawa M, Deguchi K. Physiologic role of enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery. ASAIO Trans 1987;33:505-9.
24. Segesser LK, Weiss BM, Pasic M, Garcia E, Turina MI. Risk and benefit of low systemic heparinization during open heart operations. Ann Thorac Surg 1994;58:391-8.
25. Øvrum E, Brosstad F, Åm Holen E, Tangen G, Abdelnoor M. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation 1995;92:2579-84.
26. Sakamoto T, Kano H, Miyahara S, et al. Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke. J Heart Valve Dis 2014;23:744-51.
27. Ota T, Okada K, Kano H, Okita Y. Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage. Interact Cardiovasc Thorac Surg 2007;6:270-3.
